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Abstract
Background: Meeting place-of-death preferences is an important measure of the quality of end-of-life care. Systematic review shows 
that 42% of end-stage kidney disease patients prefer home death. Little research has been undertaken on place of death.
Aim: To understand patterns of place of death in patients with end-stage kidney disease known in one UK renal unit.
Design: A retrospective cohort study of all patients with chronic kidney disease stage 4–5, age ⩾75 and known to one UK renal 
unit, who died between 2006 and 2012. Patients were categorised into three management pathways: haemodialysis, conservative and 
pre-dialysis.
Results: A total of 321 patients (mean age, 82.7; standard deviation, 5.21) died (61.7% male). In all, 62.9% died in hospital (95% 
confidence interval, 57.5%–68.1%), 21.8% died in their usual place of residence (95% confidence interval, 17.5%–26.6%) and 15.3% died 
in an inpatient palliative care unit (95% confidence interval, 11.6%–19.5%). Management pathway and living circumstances were most 
strongly associated with place of death. Patients on the conservative pathway had four times the odds of dying out of hospital (odds 
ratio, 4.0; 95% confidence interval, 2.1–7.5; p < 0.01). Patients living alone were less likely to die out of hospital (odds ratio, 0.3; 95% 
confidence interval, 0.1–0.6; p < 0.01). There were also changes in place of death over time, with more patients dying out of hospital 
in 2012 compared to 2006 (odds ratio, 3.1; 95% confidence interval, 1.0–9.7; p < 0.05).
Conclusion: Most patients with end-stage kidney disease die in hospital, but patients managed without dialysis are significantly more 
likely to die outside of hospital. Planning ahead is key to be able to meet preference for place of death.
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Short Report
What is already known about the topic?
•• Meeting preferences for place of death is an important measure of the quality of end-of-life care provided.
•• Preference for home death in end-stage kidney disease is estimated at 42%.
•• Hospital remains the most common place of death (58% between 2001 and 2008).
What this paper adds?
•• Key factors may influence place of death in renal disease, in particular renal management pathway, living circumstances 
and development of palliative care services within renal units.
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Introduction
Meeting preferences for place of death is an important 
measure of the quality of end-of-life care provided. A sur-
vey conducted in the United Kingdom found that two-thirds 
of the public would prefer to die at home.1,2 Systematic 
review of 210 studies reported preferences for over 100,000 
people from 33 countries. Preferences for dying at home 
ranged from 31% to 87% for patients, 25% to 64% for car-
egivers and 49% to 70% for the public.3 Preference for 
home death in non-malignant conditions varies in compari-
son. Just under half of people with advanced non-malignant 
conditions reported a preference for home death4 and in 
end-stage kidney disease has been estimated at 42%.4
Data suggest recent increases in the number of home 
and hospice deaths in line with these preferences; how-
ever, hospital remains the most common place of death.5,6 
These changing trends may reflect implementation of the 
National End-of-life Care Programme in the United 
Kingdom. In England and Wales, home deaths have 
increased from 18.3% to 20.8% (between 2004 and 2010), 
although the rise was more pronounced in cancer com-
pared to non-cancer.7 There is marked incongruence 
between preferred and actual place of death, most pro-
nounced in non-cancer diagnoses.8
Several factors have been shown to be associated with 
place of death.5 Marital status is the second most important 
factor, after type of cancer; married people were more 
likely to achieve a home death than those who were single, 
divorced or widowed.5 Furthermore, a systematic litera-
ture review for patients with non-malignant conditions 
identifies that the presence of a family or informal carer is 
a key component in achieving a home death.4
The number of people with non-malignant conditions 
accessing specialist palliative care services is increasing, and 
within hospital and outpatient services now accounts for at 
least 20% of all diagnoses.9 In specialist palliative care inpa-
tient units, the proportion of patients with a non-malignant 
diagnosis has increased from 3% in 1998 to 11% in 2011.9
Aim
To understand patterns of place of death in patients with 
end-stage kidney disease known to one UK renal team.
Design
Study design was a single-centre retrospective cohort 
study. Patients with chronic kidney disease stage 4–5, age 
75 and above, and known to 1 UK renal team, who died 
over a 7-year period (2006–2012) were included. End-
stage kidney disease is recognised as a disease of older 
people and therefore due to small numbers, patients under 
the age of 75 were excluded from analysis. Patients were 
identified by the renal team and included the following 
three management pathways: haemodialysis (currently 
receiving dialysis), conservative (treatment without dialy-
sis) and pre-dialysis (estimated glomerular filtration 
rate < 20 but not receiving dialysis). The pre-dialysis man-
agement pathway includes patients who do not yet require 
renal replacement therapy and have not chosen the con-
servative care pathway. These patients are being actively 
educated and prepared for dialysis. The conservative man-
agement pathway was categorised using existing guide-
lines (International Society of Nephrology). Management 
excludes dialysis but does include interventions to delay 
progression of disease, shared decision making, active 
symptom management, advance care planning, psycho-
logical support, social and family support, and cultural and 
spiritual domains of care.10
Patients receiving peritoneal dialysis were excluded due 
to small numbers. Demographic and clinical variables were 
collected including management pathway and living cir-
cumstances, variables known to be associated with place of 
death.4,5,11 Living circumstances were divided into the fol-
lowing categories: living with a family member, living 
alone, living in a care home or living circumstances not 
documented. Data were not available for preference of 
place of death. Place of death was categorised as hospital, 
usual place of residence or inpatient palliative care unit. 
Multi-variable regression analysis was undertaken to deter-
mine the relationship with place of death. Following guid-
ance from the local Research and Design Department 
(King’s College Hospital Foundation Trust), this work was 
registered as a service evaluation project with the Clinical 
Effectiveness Team (CASS number 2892). This article fol-
lows the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) statement checklist.12
Results
A total of 321 patients were included. Patient characteris-
tics are shown in Table 1. Mean age was 82.7 (standard 
deviation (SD), 5.21). In total, 61.7% were male; 62.9% 
died in hospital (95% confidence interval (CI), 57.5%–
68.1%), 21.8% died in their usual place of residence (95% 
CI, 17.5%–26.6%) and 15.3% died in an inpatient pallia-
tive care unit (95% CI, 11.6%–19.5%). A total of 202 
Implications for practice, theory or policy
•• Planning ahead is key to be able to meet preference for place of death.
•• This is particularly important for patients receiving dialysis and those living alone.
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patients died in hospital: 35 pre-dialysis, 100 haemodialy-
sis and 67 conservative management pathway. In all, 70 
patients died in their usual place of residence: 4 pre-dialy-
sis, 16 haemodialysis and 50 conservative management 
pathway. A total of 49 patients died in a hospice: 1 pre-
dialysis, 19 haemodialysis and 29 conservative manage-
ment pathway. These data are also presented in Graph 1.
In all, 42.1% of deaths were in the haemodialysis man-
agement group (95% CI, 36.7%–47.5%), 45.5% in the 
conservative management group (95% CI, 40.1%–60.0%) 
and 12.5% in the pre-dialysis management group (95% CI, 
8.9%–16.1%). Management pathway and residential set-
ting were most strongly associated with place of death. 
There were also changes in place of death over time. 
Patients in the conservative (non-dialytic) pathway had 
four times the odds of dying out of hospital (odds ratio 
(OR), 4.0; 95% CI, 2.1–7.5; p < 0.01) (Table 2). Patients 
living alone were less likely to die out of hospital (OR, 0.3; 
95% CI, 0.1–0.6; p < 0.01) (Table 2). Those where living 
status was not documented were less likely to die out of 
hospital (OR, 0.4; 95% CI, 0.2–1.0; p < 0.05) (Table 2). 
Patients living in a care home had 5.2 times the odds of 
dying out of hospital (OR, 5.2; 95% CI, 1.8–15.0; p < 0.01) 
(Table 2). Patients dying in 2012 had 3.1 times the odds of 
dying out of hospital when compared to patients dying in 
2006 (OR, 3.1; 95% CI, 1.0–9.7; p < 0.05) (Table 2). The 
increase in out-of-hospital deaths is predominantly seen in 
the conservative management group although a trend is 
noticeable in all management pathways (Table 3, Graph 2).
Discussion
Despite preference for a home death, this study confirms 
that most patients with end-stage kidney disease die in 
hospital. This study shows that place of death varied by 
management pathway, consistent with national data, and 
out-of-hospital deaths are highest in the group of patients 
managed conservatively. In this unit, patients managed 
conservatively are reviewed in a dedicated clinic, and con-
sultations maintain focus on symptoms and preferences for 
place of care and death. In comparison, patients receiving 
haemodialysis spend nearly 50% of their time in a health 
setting. Furthermore, it is the experience of this unit that 
both patients in the pre-dialysis and haemodialysis groups 
are at a higher risk of sudden death. All of these factors 
need further exploration in future studies.
Although not statistically significant, these data suggest 
that older people are more likely to die in hospital. This 
could be the result of an ageing population, increasing 
frailty and the presence of multi-morbidity. Absence of a 
care giver at home may be a factor. Furthermore, this study 
identified that patients living in a care home had five times 
Table 1. Patient characteristics.
Patient characteristics N %
Number 321  
Sex
 Male 198 61.7
 Female 123 38.3
Place of death
 Hospital 202 62.9
 Usual residence 70 21.8
 Inpatient palliative care unit 49 15.3
Year of death
 2006 31 9.7
 2007 32 10.0
 2008 32 10.0
 2009 48 14.9
 2010 48 14.9
 2011 63 19.6
 2012 67 20.9
Marital status
 Married 139 43.3
 Widowed 39 12.1
 Not documented 124 38.6
 Single 14 4.4
 Divorced 5 1.6
Age (years)
 75–79 106 33
 80–84 106 33
 85–89 73 22.7
 90–94 28 8.7
 95–99 8 2.5
Living arrangement
 With family/friend 144 44.9
 Alone 89 27.7
 Not documented 56 17.4
 Care home 32 10
Management pathway
 Haemodialysis 135 42.1
 Pre-dialysis 40 12.5
 Conservative 146 45.5
Graph 1. Place of death based on management pathway.
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the odds of dying out of hospital. It may be that this cohort 
of patients has more detailed care plans, but the full rea-
sons for this need further research.
This study identifies factors associated with place of 
death in this population including management pathway 
and place of residence. This supports previous work and 
highlights the importance of considering management 
pathway and living circumstances, so we are able to better 
meet preferences for place of death in this population.11,13 
This study also demonstrates a change over time, with 
more patients dying out of hospital in 2012 when com-
pared to 2006 (Graph 3). This may represent the impact of 
palliative care service development within this renal unit 
for conservatively managed patients (through the 
Advanced Renal Care Project)14 and is important to con-
sider when planning services in the future.
Table 2. Odds ratios: age, management pathway, marital status, who patient lived with and year of death.
B p value Odds ratio 95% CI for odds ratio
 Lower Upper
Gender (female) 0.355 0.222 1.427 0.807 2.522
Age
 75–79 (reference) 0.966  
 80–84 −0.2 0.571 0.819 0.41 1.635
 85–89 −0.233 0.56 0.792 0.362 1.735
 90–94 −0.35 0.529 0.705 0.237 2.096
 95–99 −0.208 0.817 0.813 0.141 4.699
Mode
 Haemodialysis (reference) 0  
 Pre-dialysis −0.647 0.243 0.524 0.177 1.553
 Conservative 1.391 0 4.017 2.147 7.517
Marital status
 Married (reference) 0.767  
 Widowed 0.466 0.324 1.594 0.631 4.022
 Not known 0.225 0.535 1.252 0.616 2.546
 Single 0.669 0.325 1.951 0.516 7.385
 Divorced 0.827 0.438 2.286 0.283 18.479
Who patient lived with
 Family (reference) 0  
 Alone −1.268 0.002 0.281 0.127 0.623
 Not documented −0.83 0.049 0.436 0.191 0.997
 Care home 1.655 0.002 5.235 1.831 14.969
Year of death
 2006 (reference) 0.209  
 2007 0.074 0.913 1.077 0.287 4.039
 2008 0.69 0.294 1.995 0.55 7.233
 2009 0.905 0.136 2.472 0.751 8.134
 2010 1.116 0.065 3.053 0.934 9.976
 2011 1.209 0.036 3.35 1.084 10.35
 2012 1.141 0.048 3.131 1.01 9.708
Constant −1.986 0.001 0.137  
CI: confidence interval.
Table 3. Out-of-hospital deaths over time based on management pathway.
Year
 2006 2007 2008 2009 2010 2011 2012
Management pathway
 Haemodialysis 2 2 5 5 6 8 7
 Pre-dialysis 0 0 1 1 1 1 1
 Conservative 5 6 5 8 14 20 22
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This study was limited to the data available and we 
were therefore unable to analyse and compare patients’ 
preferred place of death with their actual place of death. 
Preferences regarding place of death have been high-
lighted as an important aspect of advance care planning 
and future work could incorporate this. We were also 
unable to specifically investigate the effect of cause of 
death on place of death. It is possible that cause of death 
may explain some of the difference in place of death in 
the different management groups. These are important 
considerations when collecting data in the future, so that 
we can better meet preference for place of death in this 
population.
Conclusion
This article identifies key factors, which may influence 
place of death in renal disease, in particular renal manage-
ment pathway, living circumstances and development of 
palliative care services. For patients receiving dialysis and 
those living alone, planning ahead is key to be able to meet 
preference for place of death.
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